• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性和惰性非霍奇金淋巴瘤:根据国际综合研讨会标准进行疗效评估

Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.

作者信息

Brepoels Lieselot, Stroobants Sigrid, De Wever Walter, Spaepen Karoline, Vandenberghe Peter, Thomas Jose, Uyttebroeck Anne, Mortelmans Luc, De Wolf-Peeters Christiane, Verhoef Gregor

机构信息

Department of Nuclear Medicine, University Hospital Gasthuisberg and Catholic University Leuven, Leuven, Belgium.

出版信息

Leuk Lymphoma. 2007 Aug;48(8):1522-30. doi: 10.1080/10428190701474365.

DOI:10.1080/10428190701474365
PMID:17701583
Abstract

Until recently, response assessment in patients with lymphoma was primarily performed by computed tomography (CT). Based on CT, International Workshop Criteria (IWC) were developed and widely used. Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is a more sensitive and specific imaging technique for the detection of residual disease in lymphoma, and Revised Integrated International Workshop Criteria (IWC + PET) were recently proposed by the members of the International Harmonization Project (IHP), which combine both imaging techniques. We determined whether these new IWC + PET-criteria, can more accurately predict outcome compared to IWC-criteria in aggressive and indolent non-Hodgkin's lymphoma (NHL), and therefore correlated IWC and IWC + PET response with time-to-next-treatment (TNT) in 69 patients with NHL. We demonstrated that IWC + PET-guidelines are highly recommended over IWC-guidelines for patients with potentially-curable and routinely FDG-avid lymphoma. In contrast, no additional value of IWC + PET was demonstrated in a small group of patients with incurable histological subtypes.

摘要

直到最近,淋巴瘤患者的疗效评估主要通过计算机断层扫描(CT)进行。基于CT制定了国际研讨会标准(IWC)并被广泛应用。氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)是检测淋巴瘤残留病灶更敏感、特异的成像技术,国际协调项目(IHP)成员最近提出了修订后的综合国际研讨会标准(IWC + PET),该标准结合了两种成像技术。我们确定与IWC标准相比,这些新的IWC + PET标准是否能更准确地预测侵袭性和惰性非霍奇金淋巴瘤(NHL)的预后,因此对69例NHL患者的IWC和IWC + PET反应与下次治疗时间(TNT)进行了相关性分析。我们证明,对于具有潜在治愈可能且常规FDG摄取阳性的淋巴瘤患者,强烈推荐使用IWC + PET指南而非IWC指南。相比之下,在一小部分组织学亚型无法治愈的患者中,未证明IWC + PET具有额外价值。

相似文献

1
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.侵袭性和惰性非霍奇金淋巴瘤:根据国际综合研讨会标准进行疗效评估
Leuk Lymphoma. 2007 Aug;48(8):1522-30. doi: 10.1080/10428190701474365.
2
Hodgkin lymphoma: Response assessment by revised International Workshop Criteria.霍奇金淋巴瘤:依据修订后的国际研讨会标准进行疗效评估
Leuk Lymphoma. 2007 Aug;48(8):1539-47. doi: 10.1080/10428190701422414.
3
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.采用国际研讨会综合标准和氟-18-氟脱氧葡萄糖正电子发射断层扫描对侵袭性非霍奇金淋巴瘤进行疗效评估
J Clin Oncol. 2005 Jul 20;23(21):4652-61. doi: 10.1200/JCO.2005.01.891. Epub 2005 Apr 18.
4
Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.全身扩散加权磁共振成像和(18)F-FDG正电子发射断层显像/计算机断层扫描可鉴别不同淋巴瘤亚型。
Clin Radiol. 2015 Nov;70(11):1229-36. doi: 10.1016/j.crad.2015.06.087. Epub 2015 Jul 22.
5
Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.18F-FDG PET/CT在新诊断淋巴瘤患者中作为分期工具的应用。
Kaohsiung J Med Sci. 2015 Mar;31(3):130-7. doi: 10.1016/j.kjms.2014.11.012. Epub 2014 Dec 26.
6
[The role of FDG-PET in staging of lymphoma and evaluation of therapeutic efficiency].[氟代脱氧葡萄糖正电子发射断层扫描在淋巴瘤分期及治疗效果评估中的作用]
Zhonghua Xue Ye Xue Za Zhi. 2009 Apr;30(4):233-6.
7
Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma.根据非霍奇金淋巴瘤的组织学亚型,监测正电子发射断层扫描的不同作用。
Korean J Intern Med. 2021 Mar;36(Suppl 1):S245-S252. doi: 10.3904/kjim.2019.376. Epub 2020 Jun 19.
8
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.(18)F-FDG 杂交正电子发射断层显像/计算机断层扫描对非霍奇金淋巴瘤患者自体干细胞移植前后临床结局的预测价值
Hematology. 2010 Feb;15(1):21-7. doi: 10.1179/102453310X12583347009739.
9
Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin's lymphoma. CCHE experience.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在儿童成熟B细胞非霍奇金淋巴瘤管理中的作用。开罗儿童血液肿瘤学中心(CCHE)的经验
J Egypt Natl Canc Inst. 2016 Jun;28(2):95-9. doi: 10.1016/j.jnci.2016.03.003. Epub 2016 Apr 25.
10
FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在霍奇金淋巴瘤和侵袭性非霍奇金淋巴瘤骨髓疾病检测中的应用及其对临床管理的影响。
Q J Nucl Med Mol Imaging. 2008 Mar;52(1):9-16.

引用本文的文献

1
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.2022 年中国抗 CD19 嵌合抗原受体 T 细胞治疗 B 细胞非霍奇金淋巴瘤毒性管理临床专家共识及指南
Cancer Biol Med. 2023 Mar 2;20(2):129-46. doi: 10.20892/j.issn.2095-3941.2022.0585.
2
Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies.抗 CD20 靶向治疗策略时代滤泡性淋巴瘤中营养和炎症为基础的风险评分的预后影响。
J Cancer Res Clin Oncol. 2022 Jul;148(7):1789-1801. doi: 10.1007/s00432-021-03758-5. Epub 2021 Aug 20.
3
How we treat mature B-cell neoplasms (indolent B-cell lymphomas).
我们如何治疗成熟 B 细胞肿瘤(惰性 B 细胞淋巴瘤)。
J Hematol Oncol. 2021 Jan 6;14(1):5. doi: 10.1186/s13045-020-01018-6.
4
A Case of Synchronous Bone Marrow Chronic Myelomonocytic Leukemia (CMML) and Nodal Marginal Zone Lymphoma (NMZL).一例同步性骨髓慢性粒单核细胞白血病(CMML)和淋巴结边缘区淋巴瘤(NMZL)病例。
Am J Case Rep. 2018 Sep 26;19:1135-1139. doi: 10.12659/AJCR.910583.
5
Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group.淋巴瘤的管理:2018年印度专家组共识文件
Indian J Hematol Blood Transfus. 2018 Jul;34(3):398-421. doi: 10.1007/s12288-018-0991-4. Epub 2018 Aug 3.
6
Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC).氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)在霍奇金淋巴瘤(HL)和非霍奇金淋巴瘤(NHL)治疗结束时进行临床评估的诊断准确性:德奥维尔标准(DC)与国际协调项目标准(IHPC)的比较。
Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1837-48. doi: 10.1007/s00259-016-3390-9. Epub 2016 May 7.
7
FDG PET/CT Response Assessment Criteria for Patients with Hodgkin's and Non-Hodgkin's Lymphoma at End of Therapy: A Multiparametric Approach.霍奇金淋巴瘤和非霍奇金淋巴瘤患者治疗结束时的 FDG PET/CT 反应评估标准:一种多参数方法
Nucl Med Mol Imaging. 2016 Mar;50(1):46-53. doi: 10.1007/s13139-015-0368-7. Epub 2015 Sep 29.
8
Molecular imaging of therapy response with (18)F-FLT and (18)F-FDG following cyclophosphamide and mTOR inhibition.环磷酰胺和mTOR抑制后使用(18)F-FLT和(18)F-FDG对治疗反应的分子成像
Am J Nucl Med Mol Imaging. 2012;2(1):110-21. Epub 2011 Dec 15.
9
Preclinical imaging of therapy response using metabolic and apoptosis molecular imaging.使用代谢和细胞凋亡分子成像进行治疗反应的临床前成像。
Mol Imaging Biol. 2011 Oct;13(5):995-1002. doi: 10.1007/s11307-010-0412-z.
10
Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET.环磷酰胺处理的 B 细胞淋巴瘤异种移植中 [18F]FDG PET 监测的剂量反应关系。
Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1688-95. doi: 10.1007/s00259-010-1479-0. Epub 2010 May 12.